title: Re: Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy. S. E. Eggener, K. A. Roehl, O. Yossepowitch and W. J. Catalona, J Urol 2006; 176: 1399-1403.
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Wagner
authors.forename: Siamak
authors.initials: S
authors.lastname: Daneshmand
authors.forename: Mitchell
authors.initials: M
authors.lastname: Sokoloff
authors.forename: John M
authors.initials: JM
authors.lastname: Barry
mesh_terms: D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000175:diagnosis*; D013997:Time Factors
chemical_list: D017430:Prostate-Specific Antigen